Jubilant Pharmova Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: JUBLPHARMA BSE: 530019
₹1028.80
▼ -19.40 (-1.85%)
Sept. 30, 2026 · NSE · nse_bhavcopy
Quality
62/100
Moderate
Valuation
37/100
Fairly Valued
Momentum
36/100
Neutral

QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral

Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.

Key Metrics

Market Capitalization
₹16,387 Cr
PE (TTM)
709.5
Industry median 36.1 (152 companies)
Price to Book
2.3
PEG (TTM)
-22.7
Institutions holding %
28.27%
FII + DII, latest filed period
Piotroski Score
7
Relative return vs Nifty50, qtr %
10.5
Relative return vs Sector, qtr %
5.4
Free Cash Flow
₹-222 Cr
as of March 31, 2026
Industry median ₹-0 Cr (198 companies)
EPS Growth (YoY)
76.92%
as of June 30, 2026
Industry median 26.14% (180 companies)
Net Profit Growth (TTM)
70.83%
as of June 30, 2026
Industry median 6.21% (175 companies)
Operating Revenue Growth (TTM)
-57.54%
as of June 30, 2026
Industry median 9.08% (175 companies)
Profit Growth (YoY)
24.53%
as of Dec. 31, 2025
Industry median 22.20% (176 companies)
Revenue Growth (YoY)
12.77%
as of June 30, 2026
Industry median 14.05% (173 companies)
Current Ratio
1.62
as of March 31, 2026
Industry median 1.84 (197 companies)
Debt to Equity
0.45
as of March 31, 2026
Industry median 0.14 (186 companies)
Interest Coverage
7.25
as of June 30, 2026
Industry median 10.58 (182 companies)
Net Margin
10.88%
as of June 30, 2026
Industry median 9.35% (179 companies)
Operating Margin (EBIT)
15.95%
as of June 30, 2026
Industry median 14.22% (181 companies)
Operating Margin (TTM)
13.91%
as of June 30, 2026
Industry median 12.41% (182 companies)
Return on Assets
2.56%
as of March 31, 2026
Industry median 5.54% (180 companies)
Return on Capital Employed
6.36%
as of March 31, 2026
Industry median 12.43% (181 companies)
Return on Equity
5.60%
as of March 31, 2026
Industry median 9.66% (179 companies)

Investment checklist

Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.

Financials

2 of 7 met
  • No Revenue is higher than a year earlier in each of the last 4 quarters
  • No Quality score is Strong (70 or more)
  • Yes Piotroski F-score is 7 or more (score 7)
  • Yes Debt to equity is below 0.5 (0.45)
  • No Return on equity is 15% or more (5.6%)
  • No Net cash flow for the latest year is positive
  • No Cash from operations is higher than the year before

Ownership

3 of 4 met
  • Yes FII/FPI or DII holding rose in the latest quarter
  • Yes Promoter holding rose or was unchanged in the latest quarter
  • No Promoter pledge is 5% of their holding or less and not rising (6.6% pledged)
  • Yes Insiders have not sold in the past 3 months (no open-market sale filed in the last 3 months)

Peer comparison

1 of 3 met
  • No 1-year return beats the industry median
  • No Revenue growth beats the industry median
  • Yes Profit growth beats the industry median

Value and momentum

1 of 6 met
  • No Price sits in the Buy zone of its own historical PE range (Sell Zone)
  • No Valuation score is Undervalued (70 or more)
  • No Momentum score is Bullish (70 or more)
  • No Price is above the 5, 10 and 20 day averages
  • Yes Price is above the 50, 100 and 200 day averages
  • No Latest candle has a bullish shape (hammer, dragonfly doji, white marubozu)

Price

Download CSV

PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.

RSI (14) (same adjusted close series as the price chart above)

MACD (12, 26, 9) (same adjusted close series as the price chart above)

Relative Returns (vs NIFTY 50)

Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.

Price range

Day return
-1.9%
Low 1021.6000 · High 1063.1000
1W return
-2.8%
Low 1021.6000 · High 1089.6500
1M return
16.7%
Low 873.6000 · High 1091.8500
52W return
-7.6%
Low 786.0500 · High 1184.8000
Lifetime High ₹1262.6000 (Nov. 1, 2024)
Lifetime Low ₹68.3500 (Sept. 4, 2013)

Full price history and technicals →

EMA & SMA

Bullish4
Bearish2
5D
1047.2
10D
1042.4
20D
1017.2
50D
981.2
100D
969.0
200D
957.4

Delivery and volume

Day avg. delivery
51.4%
Week avg. delivery
61.6%
Month avg. delivery
46.8%

Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.

Resistance and support

1037.83
Pivot
First resistance1054.07
Second resistance1079.33
Third resistance1095.57
First support1012.57
Second support996.33
Third support971.07
Day RSI56.6
Day MFI43.4
Day MACD32.40
Day MACD signal32.64

Beta

1M0.28
3M0.27
1Y0.61
3Y0.84

Price change analysis

↑ 16.7%
Over 1 Month
LowHigh
873.601091.85
↑ 5.4%
Over 3 Months
LowHigh
847.851091.85
↑ 26.0%
Over 6 Months
LowHigh
800.051091.85
↓ -7.6%
Over 1 Year
LowHigh
786.051184.80
Legend Positive indicator Neutral indicator Negative indicator

Buy/Sell Zone

View Buy/Sell Zone →
Current PE 709.5 (own history: 573.7–740.4)
Sell Zone
Revenue (June 30, 2026)
₹67 Cr
Net profit (June 30, 2026)
₹7 Cr
Basic EPS (June 30, 2026)
₹0.4600

Ranks #35 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.

Shareholding pattern / Ownership

Shareholding summary

Jun 2026
  • Promoter47.68%
  • Mutual funds8.99%
  • FII/FPI15.87%
  • Other DII3.41%
  • Public23.50%

Largest holders

NameCategoryShares %Shares
SPB TRUSTEE COMPANY PVT LTDPromoter20.0800%31986161
HSB TRUSTEE COMPANY PVT LTDPromoter19.0000%30257475
MILLER HOLDINGS PTE LTDPromoter3.2800%5230455
REKHA JHUNJHUNWALAPublic3.2800%5224000
BANDHAN SMALL CAP FUNDPublic3.2100%5105353

As of June 30, 2026. Only holders the filing discloses individually.

Historical promoter holding

Promoters holdings were unchanged at 47.68% in Jun 2026 qtr

Historical fii holding

FII/FPI holdings decreased from 15.90% to 15.87% in Jun 2026 qtr

Historical mutual fund holding

Mutual funds holdings increased from 8.03% to 8.99% in Jun 2026 qtr

10 mutual fund schemes also hold this stock.

All shareholding details →

Latest insider trades

FiledPersonCategoryTypeQuantityValue
12 Mar 2026 Jubilant Employees Welfare Trust Other Sell 0 ₹0
1 Oct 2025 Jubilant Employees Welfare Trust Other Buy 0 ₹0
30 Sep 2025 Jubilant Employees Welfare Trust Other Buy 0 ₹0
30 Sep 2025 Jubilant Employees Welfare Trust Other Buy 0 ₹0
30 Sep 2025 Jubilant Employees Welfare Trust Other Buy 0 ₹0
24 Sep 2025 Jubilant Employees Welfare Trust Other Buy 0 ₹0
14 Aug 2025 HSB Trustee Company Private Limited and HS Trustee Company Private Limited Promoter group Pledge 0 ₹220.89 Cr
14 Aug 2025 SPB Trustee Company Private Limited and SS Trustee Company Private Limited Promoter group Pledge 0 ₹220.89 Cr
16 Jun 2025 Jubilant Enpro Private Limited Promoter group Sell 0 ₹0
16 Jun 2025 Nikita Resources Private Limited Promoter group Sell 0 ₹0

All insider and SAST disclosures →

DateClientDealActionQuantityPriceExchange
13 Jun 2025 NIKITA RESOURCES PRIVATE LIMITED Bulk Sell 1,962,434 1060.3700 NSE
13 Jun 2025 KOTAK MAHINDRA MUTUAL FUND Bulk Buy 1,693,434 1060.0000 NSE
13 Jun 2025 KOTAK FUNDS - INDIA MIDCAP FUND Bulk Buy 1,593,500 1060.0000 NSE
13 Jun 2025 JUBILANT ENPRO PRIVATE LIMITED Bulk Sell 2,116,000 1060.0000 NSE
18 Mar 2025 EAST BRIDGE CAPITAL MASTER FUND LIMITED Block Sell 623,585 856.2500 NSE
18 Mar 2025 EAST BRIDGE CAPITAL MASTER FUND I LTD Block Buy 623,585 856.2500 NSE
18 Mar 2025 EAST BRIDGE CAPITAL MASTER FUND LIMITED Block Sell 623,585 856.2500 NSE
18 Mar 2025 EAST BRIDGE CAPITAL MASTER FUND I LTD Block Buy 623,585 856.2500 NSE
13 Sep 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Buy 825,289 1157.7200 NSE
13 Sep 2024 GRAVITON RESEARCH CAPITAL LLP Bulk Sell 825,289 1158.1800 NSE

All bulk and block deals →

Last 12 months ₹5.00 per share
Dividend yield 0.49%
Ex-dateSubjectPer share (₹)Record date
24 Jul 2026 Dividend - Rs 5 Per Share 5.0000 24 Jul 2026
25 Jul 2025 Dividend - Rs 5 Per Share 5.0000 25 Jul 2025
2 Aug 2024 Dividend - Rs 5 Per Share 5.0000 2 Aug 2024
10 Aug 2023 Dividend - Rs 5 Per Share 5.0000 10 Aug 2023
11 Aug 2022 Dividend - Rs 5 Per Share 5.0000 12 Aug 2022
5 Aug 2021 Dividend - Rs 5 Per Share 5.0000 6 Aug 2021
9 Mar 2020 Interim Dividend - Rs 5 Per Share 5.0000 11 Mar 2020
12 Sep 2019 Annual General Meeting/Dividend - Rs 4.50 Per Share 4.5000 —
12 Sep 2018 Annual General Meeting/Dividend Rs 3 Per Share 3.0000 —
16 Aug 2017 Annual General Meeting/ Dividend - Rs 3/- Per Share 3.0000 —

Corporate Actions

Full history (27 events) →

Bonuses, splits, buybacks and other events. Dividends are listed separately above.

Ex-dateTypeSubject
—NAME_CHANGEName changed from JUBILANT LIFE SCIENCES LIMITED to JUBILANT PHARMOVA LIMITED
—NAME_CHANGEName changed from JUBILANT ORGANOSYS LTD. to JUBILANT LIFE SCIENCES LIMITED
—NAME_CHANGEName changed from Vam Organic Chemicals Ltd. to Jubilant Organosys Ltd.
4 Feb 2021MERGER Demerger
25 Nov 2010MERGERScheme Of Demerger

All corporate actions →

Quarterly results, AGMs, buybacks and other board-approved business.

DatePurposeResults
10 Aug 2026 Financial Results Yes
7 Aug 2026 Financial Results Yes
22 May 2026 Financial Results/Dividend Yes
6 Feb 2026 Financial Results Yes
31 Oct 2025 Financial Results Yes

Corporate Announcements

All 1031 announcements, with search →

Exchange disclosures (NSE and BSE), most recent first.

All announcements →

SWOT

Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.

Strengths

  • Healthy liquidity (Current Ratio 1.62)

Weaknesses

  • Low Return on Equity (5.6%)

Opportunities

Data unavailable.

Threats

  • PE above 35 (709.5) -- priced for continued strong execution

Data unavailable (no single-stock futures or options activity on record for this company).

Part of: NIFTY 500

Frequently asked questions about Jubilant Pharmova Limited

Where is the share price?

The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.

Where are the financial results?

The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.

Who owns the company?

The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.

Does Tradinity give buy or sell advice?

No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.